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2.1

Overview of in vitro firefly Luciferase complementation assay
(FLCA) system. (A) With interaction of the protein pair, the N
and C domains of luciferase (NFLuc and CFLuc, respectively) reconstitute the active site of the enzyme. The amount of NC complex is correlated with the affinities of the protein pair in question.
(B) Upon the addition of the substrates, LH2 and ATP, catalysis
occurs in a two step process. The enzyme first adenylates the
substrates LH2 and ATP, forming the intermediate LH2 -AMP.
The intermediate is then oxidized to form L-oxyluciferin (L-oxy)
during the light emission reaction. Alternatively, the intermediate is oxidized to form dehydroluciferyl-AMP (L-AMP) without
emitting light. Both products inhibit luciferase competitively.
NFLuc has small amounts of activity on its own [38, 3]. . . . . . . . . . . . . . . . . . . . . .
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The key residues of the N domain (grey and purple) and the C
domain (pink). When firefly luciferase is split, part of the enzyme
is common to both NFLuc and CFLuc (purple). This region
primarily consists of the flexible linker region between the N and
C terminal domains of firefly luciferase. As indicated here, the
C domain and CFLuc contains the key residues for adenylation
(red, K529) and oxidation (green, K443), while the N domain
and NFLuc contains the key binding residue (blue, H245). Image
generated using Visual Molecular Dynamics (VMD) software
with the crystal structure of luciferase solved by Conti et al [15, 9]. . . . . . . . . . .

4

The chemical reactions catalyzed by firefly luciferase. Firefly luciferase adenylates LH2 to form the intermediate, LH2 -AMP.
O2 is added to the intermediate, forming an unstable dioxetanone. The dioxetanone spontaneously generates CO2 and Loxyluciferin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5

Luminescence kinetics of full length luciferase (black) and the
FLCA (red) are different. Changes in the relative luminescence
of full length luciferase and the FLCA in vitro were monitored
every 0.2 s and 0.1 s, respectively, for 120 s in white 96-well
plates. Differences in sampling time are due to the abilities of
the luminometers used. Detected luminescence was normalized
so that the maximum luminescence in each assay is 1. Notice that
full length firefly luciferase kinetics has a sharp peak within 1 s
followed by quick decay. On the other hand, split firefly luciferase
has a more delayed peak and slower decay. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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2.2

Diagram describing the complete set of interactions used to develop a mathematical model for the FLCA. The interaction of the
protein pair (orange arrows) fused to NFLuc (grey panels) and
CFLuc forms an NC complex (white panels) and reconstitutes
enzymatic activity. The reconstituted activity produces luminescence by the adenylation and oxidation of LH2 . NFLuc contains
all known substrate binding residues and can catalyze the reactions on its own, so we assume that some luminescence can
be produced without the interaction of the protein pair [38, 3].
The mathematical model takes into account both NC complex
interactions and the interactions of NFLuc only. The equations
describing the reactions of NFLuc mirror that of the NC complex. ”x” refers to variable number in the model, and ”c” refers
to the reaction rate parameter. Association rates are given odd
numbered parameters, where applicable. N: NFLuc. NC: Interacting NFLuc and CFLuc. A: ATP. L: LH2 . NC-A: NC bound to
ATP. NC-L: NC bound to LH2 . NC-LA: NC bound to both substrates. NC-I: NC bound to the intermediate, LH2 -AMP. I: Free
LH2 -AMP. NC-LOXY: NC bound to L-oxyluciferin. NC-LAMP:
NC bound to L-AMP. LOXY: Free L-oxyluciferin. LAMP: Free
L-AMP. LIGHT: Observed luminescence. N-A: N domain bound
to ATP. N-L: N bound to LH2 . N-LA: N bound to both substrates. N-I: N bound to the intermediate, LH2 -AMP. N-LOXY:
N bound to oxyluciferin. N-LAMP: N bound to L-AMP. Not
shown: CFLuc binding/unbinding (x21 ). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

3.1

Kinetics of full length firefly luciferase is independent of concentration. (A) Kinetics at 150 nM of firefly luciferase. (B) Kinetics
at 450 nM of firefly luciferase. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17

3.2

Parameter estimation using NFLuc alone in vitro luminescence
kinetics data. Data originally published in [38] was digitized
using Plot Digitizer [16]. Digitized data was curve fit to estimate
parameters unavailable from previously published papers. (A)
The addition of 3.7 nM LH2 -AMP to 1 µM NFLuc shows a sharp
peak. This curve fit provided an estimation of the adenylation
forward and reverse rates. (B) When a substrate solution (300
µM LH2 , 10 mM ATP) is added to 1 µM NFLuc, the luminescence
kinetics have a slow rise and no peak. This curve fit provided
more optimized values for the available NFLuc only binding and
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3.3

Determination of the degradation rate of NFLuc and CFLuc at
37 . Previously the heat stability of NFLuc and CFLuc was
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rate, the RLU values were digitized using PlotDigitizer and the
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incubation at 37 (shown in Fig. 2.1, Fig. 3.5), the degradation
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luminescence kinetics data without any incubation (see Fig. 3.6),
probes were not incubated, but an average experimental delay
of approximately 1 s is assumed due to the use of 96-well plates. . . . . . . . . . . . . . . 19

3.5
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Abstract
The firefly luciferase complementation assay is widely used as a bioluminescent reporter
technology to detect protein-protein interactions in vitro and in vivo. Firefly luciferase
oxidates its substrate, luciferin, resulting in the emission of light. A previous study suggests
that the firefly luciferase complementation assay has different luminescence kinetics from
full length luciferase. The mechanism behind this is still unknown. Although half of the
previously published studies utilizing the firefly luciferase complementation assay consider
it quantitative. To understand how the molecular reactions and the changes in the affinity of the protein pair affect experimental results, a mathematical model was constructed.
This suggests that previously published studies should be considered qualitative, unless an
additional experiment is performed. This new model demonstrates that the luminescence
measured is not linearly correlated with the affinity of the protein pair. The model is then
used to design a new experiment which allows the firefly luciferase complementation assay
to be used quantitatively to detect changes of affinity.

xi

Chapter 1
Introduction
1.1

The firefly luciferase complementation assay
The firefly luciferase complementation assay (FLCA) is an assay that detects proteinprotein interactions in vitro as well as in vivo both at the cellular and organismal level
[68, 23]. The assay detects the bioluminescence that is emitted during the oxidation of
the substrate, D-Luciferin (LH2 ). In the assay, the N-terminal and C-terminal domain of
firefly luciferase (NFLuc and CFLuc, respectively) are genetically fused to a protein pair of
interest ([88]). When the protein pair interacts luminescence is observed.
The FLCA can be used in many systems. In the in vitro assays previously conducted
[28], the substrates LH2 and ATP are added to a 96-well plate containing the enzyme.
Luminescence is measured in relative units (RLU) as photomutlipler tubes are used to
detect photons. In the in vivo assay, the cells of interest are suspended in the 96-well plate.
LH2 is brought into contact with the enzyme via diffusion through the cell membranes.
When performing FLCA in a live mouse, LH2 is injected into a tail vein [42]. The typical
luminescence kinetics of firefly luciferase include a peak within a few seconds followed by
a gradual decay, although the FLCA kinetics have a slower peak and decay [12, 28]. The
maximum relative luminesence (RLU) is generally used to evaluate the interaction of the
protein pair.
1.1.1 Problems with experimental interpretation
Although the FLCA is valued for simplicity of the assay, it is not a simple system from
a enzymatic reaction point of view (Fig. 1.1). While NFLuc alone has residual enzymatic
activity (binding and catalysis of the substrates), the C domain is key in increasing the
efficiency of the catalytic steps [38, 3, 6, 8]. Hence in the FLCA, the affinity of a protein pair
of interest fused to NFLuc or CFLuc should influence the luminescence output by altering
the interaction between NFLuc and CFLuc.
Bioluminescent complementation assays have the advantage of being usable in vivo
without disrupting the cell’s environment [88]. The firefly luciferase complementation assay was designed to be a bioluminesent reporter technology in vivo. To establish it as a
viable technique, it was determined that NFLuc alone created low enough luminesence to
be considered background in vivo [88]. Western blotting was used to show that the enzyme
is being reconstituted upon the interaction of the proteins fused to NFLuc and CFLuc. It
was also found that the FLCA could detect protein interactions in human embryonic kidney
cells (HEK) and in living mice [88].
Disagreement on the interpretation of FLCA data The interpretation of previously
published FLCA data ranges from the presence or absence of protein interactions to quantitative measurement of the protein interaction (i.e. [41] to [87]). Some of the previously
published articles claim that the maximum RLU detected during the assay is quantitative
1

(A)

(B)

Figure 1.1: Overview of in vitro firefly Luciferase complementation assay (FLCA) system.
(A) With interaction of the protein pair, the N and C domains of luciferase (NFLuc and
CFLuc, respectively) reconstitute the active site of the enzyme. The amount of NC complex
is correlated with the affinities of the protein pair in question. (B) Upon the addition of the
substrates, LH2 and ATP, catalysis occurs in a two step process. The enzyme first adenylates
the substrates LH2 and ATP, forming the intermediate LH2 -AMP. The intermediate is then
oxidized to form L-oxyluciferin (L-oxy) during the light emission reaction. Alternatively,
the intermediate is oxidized to form dehydroluciferyl-AMP (L-AMP) without emitting light.
Both products inhibit luciferase competitively. NFLuc has small amounts of activity on its
own [38, 3].
because the maximum RLU depends upon the presence of interaction between proteins
and the amount of proteins present [21]. From 46 previously published articles using the
FLCA, 49% interpreted the data quantitatively (i.e. [41] to [87]). In such articles, FLCA
data are considered quantitative because of an assumption that the reconstituted activity
of split firefly luciferase is entirely and linearly dependent upon the amount of a protein
pair interacting with each other, which in turn is dependent upon the affinity.
In Chen et al, 9 pairs of proteins known to interact in plants were fused to NFLuc or
CFLuc and the FLCA was performed in vivo [41]. Bacterial effector proteins from Pseudomonas syringae were used as bait, and their various protein targets as prey proteins. Their
protein targets included proteins involved in the E3 ligase complex, chaperone complex,
disease resistance, and transcription factors. They also mutated the protein targets of the
effector proteins to serve as negative controls for the interaction. High luminescence was
observed for the positive interaction pairs, whereas low luminescence for the control pairs.
From this, they concluded that if the amount of interacting bait and prey proteins could be
2

quantified using a Western blot, the affinity of the interacting proteins could be deduced
from the RLU.
Another paper had a similar conclusion. In Li et al, 12 AUX/IAA proteins (plant hormone binding proteins) were fused to NFLuc as the bait. The prey consisted of 8 carboxyterminal domains of ARF proteins (plant transcription factors) which were fused to CFLuc
[51]. The carboxy-terminal domain of ARF is known to dimerize with AUX/IAA proteins,
although it was unknown which of the 12 proteins it would interact with in vivo. They
found high variation in the observed luminescence, and performed co-immuno precipitation
to find relative concentrations of NFLuc bound to CFLuc for some protein pairs. They
found a linear relationship between amount of NFLuc bound to CFLuc, and concluded the
luminescence is linearly correlated with the affinity of the protein pair.
However, a relationship between changes of the affinity of the protein pair and the luminescence detected in the FLCA has not been quantitatively understood. In fact, it has been
shown previously that the kinetics of luminescence production in the FLCA is very different
from that in full length firefly luciferase [3, 38, 21]. Without a thorough understanding of
the cause for these changes in the luminescence kinetics, or a demonstration of a linear
relationship between protein interaction and luminescence, the FLCA cannot reasonably
be considered quantitative. The purpose of this thesis is to quantitatively understand the
relationship between changes of the affinity of a protein pair and the luminescence detected
in the FLCA using a mathematical model. The model is built upon the known enzymatic
reactions and the equilibrium constants identified for both firefly luciferase and the protein pair. Using the model, quantitative or qualitative nature of FLCA data will be analyzed.
1.2 The firefly luciferase reaction
1.2.1 Structure of firefly luciferase
Firefly luciferase is a 62 kDa oxygenase encoded by 550 amino acids [9]. X-ray crystallography has revealed that the N domain is encoded in amino acids 4-436, and the C domain in
amino acids 440-544 [9]. There is a flexible hinge region between the two domains at amino
acids 436-440 [9]. The flexible linker region allows the C domain to change conformation
during the oxidation step, allowing the catalytic residue to come in contact with the substrate (Fig. 1.2). Both of the primary amino acids involved in catalysis are on the C domain.
Amino acid K429 is responsible for adenylation, while K443 oxidizes the substrates [8, 6].
Gene mutation studies identified binding sites for LH2 and ATP encoded in amino acids
213-348 of the N domain [7]. N domain residue H245 is considered the key binding residue,
as it is highly conserved throughout the adenylase family in addition to being in the region
identified as responsible for binding of substrates [7]. The firefly luciferase complementation
assay design consists of the enzyme split into two portions, the N and C domains. NFLuc
consists of amino acids 1-437, and CFLuc contains 395-547 [28]. The overlapping region
common to both NFLuc and CFLuc, amino acids 395-437, includes the flexible linker region
and part of the N domain.
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Figure 1.2: The key residues of the N domain (grey and purple) and the C domain (pink).
When firefly luciferase is split, part of the enzyme is common to both NFLuc and CFLuc
(purple). This region primarily consists of the flexible linker region between the N and C
terminal domains of firefly luciferase. As indicated here, the C domain and CFLuc contains
the key residues for adenylation (red, K529) and oxidation (green, K443), while the N
domain and NFLuc contains the key binding residue (blue, H245). Image generated using
Visual Molecular Dynamics (VMD) software with the crystal structure of luciferase solved
by Conti et al [15, 9].
1.2.2 Mechanism of Luminesence
The molecular mechanism of full length firefly luciferase reaction has been well established [19, 11, 25, 89]. During adenylation step, ATP and LH2 are adenylated to form the
intermediate luciferyl-adenylate (LH2 -AMP) (Reaction 1.1). The oxygen on the carboxyl
group of LH2 acts as a nucleophile (Fig. 1.2.2), and the α phosphorous of ATP acts as an
electrophile [25]. Mg2+ is utilized by ATP to shield the negative charges and aid in the
electrophilic action of the phosphorous. AMP is transferred to LH2 , forming the intermediate, LH2 -AMP, and pyrophosphate leaves. Luciferase then oxidizes this intermediate via
the following generally accepted mechanism [6]. Lysine 529 removes a proton from the C4
carbon, creating a carbanion. O2 is then added to the carbanion, forming a dioxetanone
after AMP leaves. The instability of the dioxetanone causes it to spontaneously generate
CO2 (Reaction 1.2). This creates oxyluciferin in a singlet excited state. As oxyluciferin
decays to its ground state, it releases a photon and luminesence is observed (Reaction 1.3).
The quantum yield of firefly luciferase is approximately one photon released per excited
oxyluciferin [9].
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Figure 1.3: The chemical reactions catalyzed by firefly luciferase. Firefly luciferase adenylates
LH2 to form the intermediate, LH2 -AMP. O2 is added to the intermediate, forming an
unstable dioxetanone. The dioxetanone spontaneously generates CO2 and L-oxyluciferin.

Luc + LH2 + ATP

M g 2+

Luc · LH 2 AMP + O2

Luc · LH 2 AMP + P Pi

Luc · L Oxy? + AMP + CO2

Luc · L Oxy?

Luc · L Oxy + hv

Luc · LH 2 AMP + O2

Luc · L AMP + H2 O2

{1.1}
{1.2}
{1.3}
{1.4}

In an alternate pathway, LH2 -AMP is oxidized to form dehydroluciferin-AMP (L-AMP)
and hydrogen peroxide, without any emission of light (Reaction 1.4) [89]. This is known
as the dark reactions. The dark reactions account for approximately 20% of all luciferase
activity [25]. Both of these products inhibit luciferase activity competitively against LH2
[12]. It was found that the main cause for the quick decay of luminesence in firefly luciferase
kinetics is accumulation of the inhibitors ([25]).
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Table 1.1: The Body of FLCA Data (part 1)

Interpretation Protein Pairs
Quantitative 9 interacting protein pairs
Quantitative
Peptides which interact upon radiation
induced apoptosis
Qualitative
Membrane protein localization
Quantitative
NC complex formed when target RNA
binds to RNA bound to NFLuc or
CFLuc
Histones H2A and H2B and Arabidopsis
Qualitative
membrane proteins SYP61 and SYP51
Quantitative
Amyloid β dimers/oligomers
Qualitative
Large-scale screening of kinases and kinase inhibitors
Fbox proteins known to interact and
Qualitative
transcription factors
Qualitative
Proteins involved in forming integrinlink kinase-mediated protein complex
Qualitative
Andgrogen and liver receptor binding
elements
Quantitative Arabidopsis FRB and human FKBP; 8
ARFs and 12 AUX proteins
Qualitative
Kinase and regulator proteins
Qualitative
Bacterial pathogenic effector and potential tomato target proteins
Quantitative
Chemokines and receptor proteins
Qualitative
Qualitative
Quantitative
Quantitative
Quantitative
Qualitative

High-motility-group box protein and flu
virous nucleoproteins
(review)
Oncological kinases
Cellular defense proteins and their activators
Chimokene ligands
protein kinase and interaction partners
during drought

System
Plants
Mice

[41]
[42]

Plants
in vitro

[43]
[44]

Protoplasts

[45]

in vitro
in vitro

[46]
[47]

Filamentous
comycetes
HEK

as- [48]
[49]

HeLa human cells

[50]

Protoplasts

[51]

Plants
Plants

[52]
[53]

Human breast cancer [54]
cells
HEK
[55]
plant
(review)
HEK

[56]
[57]
[58]

homo sapiens mam- [59]
mary cells
Protoplasts
[60]

: Papers which claim linear correlation between RLU and Kd . : Papers which obtained

saturation curves.
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Table 1.2: The Body of FLCA Data (part 2)

Interpretation Protein Pairs
Quantitative
Drug and drug targets
Qualitative
Calcium sensor and activator proteins
Qualitative
Rapamycin-dependent interactions between FRB and FKBP proteins
Qualitative
Receptor kinase and signaling proteins
Quantitative
α syn nuclein oligomers
Qualitative
Adipose hormone and potential ligands
Quantitative
Apoptosome complex proteins
Quantitative
(review)
Tumor necrosis factor protein and tarQualitative
get proteins
Quantitative
Ubiquitin modifier and target proteins
Qualitative
(review)
Quantitative
(review)
Qualitative
CpG-site binding protein complex proteins
Qualitative
Viral and glycolytic enzyme proteins
Qualitative
Chemokine receptor and target scaffolding proteins
Quantitative
Voltage gated channel complex proteins
Quantitative
(review)
Quantitative
Kinase activity which disrupts linker between enzyme domains
Qualitative
Anti-viral targets
Quantitative
Auxin uptake and efflux proteins
Qualitative
Protein complex that associates with
the circadian clock
Qualitative
Gibberellin signaling proteins
Deacetylase and its activator adn represQuantitative
sor proteins
Quantitative
RNA binding protein and repressor protein
Quantitative
Fungal transcription factor complex proteins
Quantitative
Repressor and adapter protein targets
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System
(review)
Protoplasts
Plants

[61]
[62]
[63]

Protoplasts and Plants
mice
Yeast
HEK
in vivo
HEK

[64]
[65]
[66]
[67]
[69]
[70]

Plants
in vivo
in vivo
Leaves and protoplasts

[71]
[72]
[73]
[74]

HEK
[75]
Human breast cancer [76]
cells
HEK
[77]
Plants
[78]
Human glioma cells
[79]
(review)
Plants
Protoplasts

[80]
[81]
[82]

Plants
HEK

[83]
[84]

Plants

[85]

Fungi

[86]

Protoplasts

[87]

Chapter 2
The Mathematical Model
2.1 Creation of the mathematical model
2.1.1 Existing models of firefly luciferase
Of interest to us, the kinetics of full length firefly luciferase and NFLuc have significant
differences [3, 38]. Although currently mathematical models of full legnth firefly luciferase
exist, certain key components are not taken into account in these models [17, 20]. In analyzing the kinetics of the FLCA, it is apparent that its kinetics are unique from both full length
luciferase and NFLuc alone (Fig. 2.1, [38, 3]). The current models ignore many factors that
have been previously shown experimentally to be significant. Therefore the conclusions of
such full length models cannot explain the quantitative or qualitative nature of the FLCA.
Hence, the first objective of this thesis became to incorporate these missing elements and
understand how they cause the changes in kinetics.

Figure 2.1: Luminescence kinetics of full length luciferase (black) and the FLCA (red) are
different. Changes in the relative luminescence of full length luciferase and the FLCA in
vitro were monitored every 0.2 s and 0.1 s, respectively, for 120 s in white 96-well plates.
Differences in sampling time are due to the abilities of the luminometers used. Detected
luminescence was normalized so that the maximum luminescence in each assay is 1. Notice
that full length firefly luciferase kinetics has a sharp peak within 1 s followed by quick decay.
On the other hand, split firefly luciferase has a more delayed peak and slower decay.
To date, three mathematical models exist which describe the firefly luciferase reaction
pathway. The simplest model considers the system of reactions to be a simple MichaelisMenten relationship of the form shown in equation 2.1 [17]. In this equation, kcat is a
constant of unit s−1 , expressing the production of luminescence by luciferase as a velocity.
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dLight
kcat · [enzyme] · [substrate]
=
dt
Km + [substrate]

(2.1)

The most apparent problem with this assumption is that it only takes one substrate
(LH2 ) into account. ATP is a necessary substrate for the luciferase reaction, and it has a Kd
of 160 µM, an order of magnitude higher than the Kd of LH2 (16 µM) [6, 38]. In addition,
the main cause of the quick decay of the firefly luciferase kinetics is product inhibition and
this is not incorporated [25]. Another model incorporates this into a similar steady-state
equation but with product inhibition incorporated (equation 2.2) [35]. In this equation, kcat
is a constant of unit s−1 , expressing the production of luminescence by luciferase as a velocity.
dLight
=
dt
1+

[enzyme] · kcat
Ks
[substrate]

+

Ks ·[product]
Kp ·[substrate]

(2.2)

Although this equation encompasses more of the reaction than the model described
previously, the equation simplifies the random addition of two substrates, LH2 and ATP, to
the enzyme to a single substrate binding event. It fails to recognize the different affinities
of the substrates and the two products, L-oxy and L-AMP. This is demonstrated by the
model itself when it was found that curve fits produced very different substrate affinities
and catalytic rates depending upon the concentration of substrate present [35].
A model constructed by Mannienen et al incorporates every binding and catalysis rate
that luciferase undergoes [24]. However the adenylation step in this model is considered a
one-way reaction. In addition, it does not account for dark reactions or the formation of
L-AMP. The model also incorporated a regeneration step for the substrates, LH2 and ATP,
although this was not experimentally observed [24].
Model goals In summary, these existing models are not sufficient to understand the
FLCA. The first objective of this thesis is to model the entire set of binding and catalysis events that luciferase performs. The complete conceptual understanding of the firefly
luciferase reaction pathway includes the random addition of LH2 and ATP, the reversible
adenylation step, and either the production of excited L-oxy or L-AMP after oxidation. Luciferase is then reversibly inhibited by its products, which have different inhibition affinities
(Ki s). After completion of this conceptual model, it then should be adapted to represent
the FLCA by incorporating NFLuc and the NC complex interactions.
2.1.2 The basis for the FLCA model
NFLuc has catalytic activity NFLuc alone can perform the adenylation and oxidation
reactions, although the activity is 10−5 fold of the full length [38]. CFLuc forms the ”active
site” by coupling the adenylation and oxidation steps [32, 3]. The relative oxidation rate
of the N domain alone is approximately 100 times less than full length luciferase [3]. Since
9

NFLuc and CFLuc are continuously binding and unbinding, depending upon the affinity of
the protein pair attached, the activity of NFLuc alone during the FLCA will not necessarily
be as minimal as that of NFLuc alone. Previous data suggests that the C domain of firefly
luciferase undergoes a conformational change, allowed by the flexible linker region which
connects it to the N domain. This conformational change allows for improved contact by
the catalytic residues [3, 38]. Since CFLuc will continuously bind and unbind NFLuc during
the FLCA, it is reasonable that it might have a significant effect upon the luminescent
yield. The model will therefore incorporate a set of equations representing the binding and
catalysis activities of NFLuc when not interacting with CFLuc (Fig. 2.2).
Effects of removing the C domain on the adenylation step Previous models of
full length firefly luciferase have focused almost solely on the oxidation step of the reaction
(Reaction 1.4), as this is the point when light is released. Only one model of the three existing models considered adenylation [24]. However, previous data suggests that the removal
of the C domain has significant effects on the adenylation step [6, 8, 3, 38]. A series of
mutagenesis experiments by Branchini et al mutated the two primary catalysis-enhancing
residues on the C domain, Lys529 and Lys443 [6, 8]. The oxidation rate of the mutant
decreases by 105 times compared to full length luciferase, while the adenylation rate drops
100 times [6]. In the same experiments, it was found that the affinity to both ATP and
LH2 substrates increased about 5 times [6]. Similar relative changes were found in a study
comparing full length luciferase and NFLuc alone directly [38]. These studies were used as
the primary sources for estimates concerning binding and catalysis rates by NFLuc and the
NC complex in the model of the FLCA reactions.
2.1.3 The system of differential equations representing the FLCA
In order to understand the reasons for the different kinetics of the FLCA and their
implications for data analysis, a mathematical model was created that describes the set of
reactions of split firefly luciferase. The model was based on the conceptual model outlined
above, and with the additional consideration of interacting and non-interacting NFLuc and
CFLuc.
Model assumptions Our assumptions in the created model are summarized in (Fig. 2.2).
Briefly, we assume that NFLuc and CFLuc reconstitute the ”active site” upon the association of the protein pair fused to NFLuc and CFLuc [88]. ATP and LH2 , the substrates of
firefly luciferase, can bind to NFLuc independently from CFLuc [7]. With both substrates
bound, NFLuc catalyzes the adenylation and oxidation reactions but at a much lower rate
than when CFLuc is present [1, 3]. The reconstituted ”active site” is disrupted by constant
dissociation of the protein pair fused to NFLuc and CFLuc. The two products, L-oxy and
L-AMP, inhibit luciferase competitively and do not dissociate instantly upon formation
[25, 12]. L-oxy is the light emitter and the primary product, while L-amp does not produce
light (dark reaction)[25]. The frequency of the dark reactions increases when the enzyme is
split [8]. A system of ordinary differential equations (ODEs) were written based on these
assumptions (ODE 2.1.3) and initial estimates for the parameters were obtained from the
literature (Table 2.1).
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Figure 2.2: Diagram describing the complete set of interactions used to develop a mathematical model for the FLCA. The interaction of the protein pair (orange arrows) fused to NFLuc
(grey panels) and CFLuc forms an NC complex (white panels) and reconstitutes enzymatic
activity. The reconstituted activity produces luminescence by the adenylation and oxidation
of LH2 . NFLuc contains all known substrate binding residues and can catalyze the reactions
on its own, so we assume that some luminescence can be produced without the interaction
of the protein pair [38, 3]. The mathematical model takes into account both NC complex
interactions and the interactions of NFLuc only. The equations describing the reactions of
NFLuc mirror that of the NC complex. ”x” refers to variable number in the model, and ”c”
refers to the reaction rate parameter. Association rates are given odd numbered parameters,
where applicable. N: NFLuc. NC: Interacting NFLuc and CFLuc. A: ATP. L: LH2 . NC-A:
NC bound to ATP. NC-L: NC bound to LH2 . NC-LA: NC bound to both substrates. NC-I:
NC bound to the intermediate, LH2 -AMP. I: Free LH2 -AMP. NC-LOXY: NC bound to
L-oxyluciferin. NC-LAMP: NC bound to L-AMP. LOXY: Free L-oxyluciferin. LAMP: Free
L-AMP. LIGHT: Observed luminescence. N-A: N domain bound to ATP. N-L: N bound
to LH2 . N-LA: N bound to both substrates. N-I: N bound to the intermediate, LH2 -AMP.
N-LOXY: N bound to oxyluciferin. N-LAMP: N bound to L-AMP. Not shown: CFLuc
binding/unbinding (x21 ).
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ODE 2.1.3
System of ordinary differential equations describing the FLCA
dx1
= −c1 · x1 · x21 + c2 · x2 − c9 · x1 · x6 + c10 · x16 − c7 · x1 · x3 + c8 · x15
dt
− c24 · x1 · x14 + c25 · x19 − c26 · x1 · x12 + c27 · x20 − c15 · x1 · x9
+ c16 · x18
dx2
= c1 · x1 · x21 − c2 · x2 − c3 · x2 · x3 + c4 · x4 − c5 · x2 · x6 + c6 · x5
dt
− c21 · x2 · x12 + c22 · x11 − c19 · x2 · x14 + c20 · x10 − c15 · x2 · x9
+ c16 · x8
dx3
= −c3 · x2 · x3 + c4 · x4 − c3 · x5 · x3 + c4 · x7
dt
− c7 · x1 · x3 + c8 · x15 − c7 · x16 · x3 + c8 · x17
dx4
= c3 · x2 · x3 − c4 · x4 − c5 · x4 · x6 + c6 · x7 + c1 · x15 · x21 − c2 · x4
dt
dx5
= −c3 · x5 · x3 + c4 · x7 + c5 · x2 · x6 − c6 · x5 + c1 · x16 · x21 − c2 · x5
dt
dx6
= −c5 · x2 · x6 + c6 · x5 − c5 · x4 · x6 + c6 · x7
dt
− c9 · x1 · x6 + c10 · x16 − c9 · x15 · x6 + c10 · x17
dx7
= c3 · x5 · x3 − c4 · x7 + c5 · x4 · x6 − c6 · x7 + c1 · x17 · x21 − c2 · x7
dt
− c11 · x7 + c12 · x8
dx8
= c11 · x7 − c12 · x8 + c1 · x18 · x21 − c2 · x8 − c18 · x8 + c15 · x2 · x9
dt
− c16 · x8
dx9
= −c15 · x2 · x9 + c16 · x8 − c15 · x1 · x9 + c16 · x18
dt
dx10
= c18 · x8 · (1 − c23 ) + c1 · x19 · x21 − c2 · x10 + c19 · x2 · x14 − c20 · x10
dt
dx11
= c18 · c23 · x8 + c1 · x20 · x21 − c2 · x11 + c21 · x2 · x12 − c22 · x11
dt
dx12
= −c21 · x2 · x12 + c22 · x11 − c26 · x1 · x12 + c27 · x20
dt
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(2.3)

(2.4)

(2.5)

(2.6)
(2.7)
(2.8)

(2.9)

(2.10)

(2.11)
(2.12)
(2.13)
(2.14)
(2.15)

dx13
dt
dx14
dt
dx15
dt
dx16
dt
dx17
dt

= c18 · x8 · (1 − c23 ) − x13 + c17 · x18 · (1 − c23 )

(2.16)

= −c19 · x2 · x14 + c20 · x10 − c24 · x1 · x14 + c25 · x19

(2.17)

= c7 · x1 · x3 − c8 · x15 − c9 · x15 · x6 + c10 · x17 − c1 · x15 · x21 + c2 · x4

(2.18)

= c9 · x1 · x6 − c10 · x16 − c7 · x16 · x3 + c8 · x17 − c1 · x16 · x21 + c2 · x5

(2.19)

= −c13 · x17 + c14 · x18 + c9 · x15 · x6 − c10 · x17 + c7 · x16 · x3
− c8 · x17 − c1 · x17 · x21 + c2 · x7

dx18
= c13 · x17 − c14 · x18 − c1 · x18 · x21 + c2 · x8 − c17 · x18 + c15 · x1 · x9
dt
− c16 · x18
dx19
= c17 · (1 − c23 ) · x18 − c1 · x19 · x21 + c2 · x10 + c24 · x1 · x14 − c25 · x19
dt
dx20
= c17 · c23 · x18 − c1 · x20 · x21 + c2 · x11 + c26 · x1 · x12 − c27 · x20
dt
dx21
= −c1 · x21 · x1 − c1 · x21 · x15 − c1 · x21 · x16 − c1 · x21 · x17
dt
− c1 · x21 · x20 − c1 · x21 · x19 + c2 · x2 + c2 · x4 + c2 · x5 + c2 · x11
+ c2 · x10 + c2 · x7 − c1 · x21 · x18 + c2 · x8

(2.20)

(2.21)
(2.22)
(2.23)

(2.24)

Applicability of ODEs to biological systems Ordinary differential equations express
the change in a function with respect to a variable. In our case, some of the variables
we consider are enzyme concentration and substrate concentration. When an equation is
differentiated, the solution can be thought of as the rate of change, or slope of the function
with respect to a variable. Since the rate of change is already known by previous experiments detailing the interaction pathways of enzymes, we can write the differential equations
directly. As the changes in a biological system are occurring over time, these equations are
written with respect to the change in time.
Differential equations are useful as many biological processes can be considered in terms
of rates. The rate at which an enzyme binds its substrate, for example, can be expressed as
kon . This kon can be directly and objectively measured, but when considering the amount
of substrate bound at a given point in time, the rate can be modified to reflect the changing
conditions, following the law of mass action. For example, the amount of substrate available
to bind the enzyme will affect the amount of enzyme-substrate complex formed in the next
time unit, although the kon does not change. The amount of enzyme available will also affect
this value.
Brief overview of the ODEs The variable and parameter assignments can be seen in
Fig. 2.2. Association interactions are expressed by the appropriate forward parameter kon .
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We can then modify the association by the concentration of the two interacting species.
For example, in equation 2.5, the interaction of NFLuc to ATP is expressed by the kon
parameter specific to this interaction, c7 , multiplied by the concentrations of NFLuc and
ATP at time t. Reverse interactions are expressed by reverse rate parameters, kof f , which
are also specific to that species. The dissociation of NFLuc-ATP complex is expressed by
the kof f modified by the concentration of NFLuc-ATP at time t. The concentration of any
given species is updated at every time unit by the appropriate rate. The concentration of
NFLuc decreases at the rate kon ·NFLuc·ATP but increases at the rate kof f · NFLuc-ATP.
The concentration of NFLuc, for example, is also affected by all of its other interaction and
catalysis rates.
All reactions accrue by mathematical rules. For example in equation 2.13, the amount of
L-oxy produced by the NC complex is modified by the rate 1-c23 . Parameter c23 represents
the frequency of oxidation events which are dark reactions as a number between 0 and
1. In equation 2.16, which calculates the amount of light at time t, the concentration of
light was corrected by subtraction of x13 at every time t. This is because light is not a
cumulative property, but decays very quickly. The luminometers read and plot light at some
set sampling point, which is equivalent to the model’s incremental sampling point. This
gives the effect of tracking the light produced at time t only, which is representative of
experimental data collection, which usually occurs every 0.1 s.
Incorporation of protein-protein interactions The mathematical model (ODE 2.1.3)
is applied to a protein pair to reflect experimental FLCA conditions. For this protein pair
we chose the interacting pair p53 and mdm2. P53 is a tumor suppressor protein and mdm2
regulates it by binding to it [31]. The transactivation domain of p53 is bound by mdm2
with an affinity of 212 nM [31]. The transactivation domain of p53 (residues 15-29) was
genetically attached to NFLuc, and whole mdm2 was similarly attached to CFLuc [28]. The
transactivation domain of p53 binds mdm2 with a Kd of 212 nM, and their association and
dissociation rates have been experimentally determined [31]. The relationship between the
Kd and the association and dissociation rates is shown in equation 2.25.

Kd =

kof f
kon

(2.25)

The interaction between NFLuc and CFLuc is described by an association rate (c1 )
and a dissociation rate (c2 ). These rates are assumed to be the same as the association and
dissociation rate of the protein pair themselves. In vivo, mdm2 causes the inactivation and
degradation of p53 [31].
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Table 2.1: Parameters Derived from the Literature.
Full length parameters
Luciferin Affinity
ATP Affinity
Intermediate Affinity
Net Adenylation Rate
Catalytic Activity

7.2-15 µM
160-230 µM
4.7 µM
0.001 s−1
0.23 s−1

[38, 6]
[38, 6]
[6]
Estimated [6]
[6]

NFLuc only parameters
Luciferin Affinity
ATP Affinity
Intermediate Affinity
Net Adenylation Rate
Catalytic Activity

26-67 µM
560-6900 µM
0.55 µM
0.00001 s−1
0.0000311 s−1

[38, 6]
[38, 6]
[6]
Estimated [6]
[6]

Shared parameters
L-AMP Affinity
3.8 nM
Oxyluciferin Affinity
500 nM
Dark Reaction Frequency
> 0.2
Degradation of Split Luciferase 0.00136 s−1
Protein parameters
P53/MDM2 Affinity
kon of P53 and MDM2
kof f of P53 and MDM2
Nutlin-3/MDM2 Affinity

212 nM
2 s−1
0.009 nM −1 s−1
216-250 nM

[34, 25, 12]
[25, 12]
[25, 8]
Calculated [28]

[31]
[31]
[31]
Calculated

Initial estimates for parameter values were taken from the literature where available. Some
values were calculated from experimental results () or estimated ( ) from relative rate
comparisons.
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Chapter 3
Results and Discussion
3.1

The FLCA model agrees with experimental data
Previous independent studies suggest that kinetics of luminescence production in full
length luciferase and the FLCA are different [3, 38, 21]. We conducted experiments which
directly compare the kinetics of luminesence production in the FLCA and full length luciferase (Fig. 2.1). In this experiment, we used 50 nM each of p53-NFLuc and mdm2-CFLuc
[28]. The protein pair p53 and mdm2 is known to interact with each other in vitro with a
dissociation constant (Kd ) of 212 nM [31]. NFLuc and CFLuc were fused to p53 and mdm2
as described previously [28].
In our experimental conditions, the luminescence kinetics of 150 nM full length firefly
luciferase was measured after adding 75 µM LH2 and 100 mM ATP. Full length firefly
luciferase shows a sharp peak within the first second, followed by fast signal decay (Fig.
2.1). These kinetics are observed regardless of the different concentrations used (Fig. 3.1)
[25]. The luminescence kinetics of split firefly luciferase shows a slower peak with slower
signal decay (Fig. 2.1). Previous data shows that the kinetics of the peak of the FLCA
kinetics are independent from protein concentrations used in the assays for protein pairs [28].
This result confirmed the previous suggestion that the kinetics of luminescence production
in full length and split firefly luciferase are different. This result also suggested that the
different luminescence kinetics are not due to insufficient substrate concentrations, or sensor
artifacting, but rather other factors.
3.1.1 Estimation of NFLuc binding and catalysis rates
The adenylation rate was estimated by curve fitting to previously published NFLuc
kinetic data [3]. We used the portion of the mathematical model which describes the binding
and catalysis of NFLuc alone by removing the portions of the equations involving CFLuc
(ODE 4.1.2). To curve fit the model to the previously published data, we digitized the
data using PlotDigitizer (Fig. 3.2) [3]. Matlab’s lsqcurvefit function was used to perform
the curve fit. The literature provided initial estimates for parameters (Table 2.1). The
curve fit produced initial estimates for the previously unknown forward and reverse NFLuc
adenylation rates, as well as more optimized values for the interaction and catalytic rates
of NFLuc alone (Table 3.2).
3.1.2 Estimation of NC complex binding and catalysis rates
Calculation of initial conditions The FLCA data used to estimate parameters was
collected after incubation of p53-NFLuc and mdm2-CFLuc at 37 for 120 s. Therefore,
prior to simulating the FLCA the initial concentration of NFLuc, CFLuc, and the NC
complex was calculated.
It was shown previously that NFLuc and CFLuc degrades when incubated at 37  [28].
The activity of the FLCA at different lengths of incubation time was recorded previously
16

(A)

(B)

Figure 3.1: Kinetics of full length firefly luciferase is independent of concentration. (A)
Kinetics at 150 nM of firefly luciferase. (B) Kinetics at 450 nM of firefly luciferase.

(A)

(B)

Figure 3.2: Parameter estimation using NFLuc alone in vitro luminescence kinetics data.
Data originally published in [38] was digitized using Plot Digitizer [16]. Digitized data was
curve fit to estimate parameters unavailable from previously published papers. (A) The
addition of 3.7 nM LH2 -AMP to 1 µM NFLuc shows a sharp peak. This curve fit provided
an estimation of the adenylation forward and reverse rates. (B) When a substrate solution
(300 µM LH2 , 10 mM ATP) is added to 1 µM NFLuc, the luminescence kinetics have a slow
rise and no peak. This curve fit provided more optimized values for the available NFLuc
only binding and catalysis rates.
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Figure 3.3: Determination of the degradation rate of NFLuc and CFLuc at 37 . Previously
the heat stability of NFLuc and CFLuc was analyzed by measuring the activity after
incubation times ranging from 0 to 60 minutes at 37 . To calculate the degradation rate,
the RLU values were digitized using PlotDigitizer and the maximum RLU values were
extracted. The RLU value for no incubation time was considered 100% activity. This was
curve fit to an equation describing degradation (Eqn. 3.1). The degradation rate was found
to be 0.00136 s−1 .
and used in this calculation. The maximum luminesence values for each incubation time
were normalized to 100% or less activity and curve fit to equation 3.1 (Fig. 3.3) [28]. The
degradation rate of NFLuc and CFLuc at 37  was calculated to be 0.00136 s−1 .
Activity = e−DegradationRate∗T ime

(3.1)

After obtaining an estimate for the degradation rate at 37, a system of equations was
written to describe the interaction of two proteins at the rates kon and koff , and their degradation at 0.00136 s−1 (See appendix C). The amount of NFLuc, CFLuc, and NC complex
at 120 s were used as the initial concentrations upon the addition of substrates (Fig. 3.4(A)).
Estimation of NC complex binding and catalysis rates We used the parameter
estimates from the literature and the improved estimates from the curve fit to NFLuc only
data (Fig. 3.2) as initial estimates for NC complex parameters. We curve fit the mathematical model describing the in vitro FLCA to experimental data obtained with the protein
pair NFLuc-p53 and CFLuc-mdm2. The predicted luminescence after optimization of the
NC complex parameters closely matches the experimental data, as shown in Fig. 3.5.
We also looked at the ability of the model to fit other data sets with different concentrations of NFLuc-p53 and CFLuc-mdm2 (Fig. 3.6). These experiments were performed under
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Figure 3.4: Determination of the initial concentration of NC complex in silico. Initial
concentration of free NFLuc-p53, free CFLuc-mdm2, and NC complex was modeled using
the affinity for p53 and mdm2 from the literature [31]. (A) For luminescence kinetic data
with incubation at 37 (shown in Fig. 2.1, Fig. 3.5), the degradation rate was included
in the calculation of initial conditions. (B) For luminescence kinetics data without any
incubation (see Fig. 3.6), probes were not incubated, but an average experimental delay of
approximately 1 s is assumed due to the use of 96-well plates.

Figure 3.5: Model simulation (red) of the luminesence kinetics of NFLuc-p53 and CFLucmdm2 using in vitro FLCA compared to the data (black) after optimization. The values for
the parameters in the mathematical model were estimated in three steps. Parameter values
were taken from the literature when able, or calculated from previous data (Table 1.1).
Additional parameter values were estimated by curve fitting the model to the luminescence
kinetics of NFLuc only [38] (Fig. 3.2). Finally, NC complex binding and catalysis rates were
optimized by curve fitting (red) to the luminescence kinetics of NFLuc-p53 and CFLucmdm2 using FLCA (black).
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the same conditions as Fig. 3.5, but there was no incubation step. However, it is reasonable
to expect some delay after addition of the enzyme solution to the 96-well plate and the
injection of the substrate solution. To reflect this, the ’incubation’ time was estimated to
be 1 s. The amount of NFLuc, CFLuc, and NC complex at 1 s were used as the initial
concentrations upon the addition of the substrates. No parameters were optimized for these
data sets with the exception of the photomultiplier tube’s effect upon the measured RLU.
The photomultiplier tube automatically magnifies the signal it detects upon detecting a
photon, either by a user-defined value or by an internal calculation.
The model reasonably fits the data with the exception of early time points. For these
experiments, 50 µL of solution containing p53-NFLuc and mdm2-CFLuc are first added to
a well in a 96-well plate. Then the luminometer injects a 50 µL substrate solution directly
into the well, and measures the luminescence immediately after. The model’s equations
assume a homogenous mixture of all species, such that it is equally likely for any compound
to come into contact with another compound. For the very early time points of the FLCA,
however, this may not be true.
3.1.3

The mathematical model predicts that the interaction of NFLuc and
CFLuc reconstitutes full length activity
The results of the curve fitting brought us a quantitative understanding of the luminescence production in FLCA. A direct comparison of the experimental and estimated values
are shown in Table 3.1, and the raw rate parameters are shown in Table 3.2. First, when the
”active site” is reconstituted through the protein interaction of p53 and mdm2, the affinity
of LH2 to NFLuc increases from 27.5 µM to 16 µM. This is comparable to the full length
affinity to LH2 , which has been measured between 7.2-16 µM [6, 38]. The affinity of ATP
increases from 683 µM to NFLuc alone to 160 µM to the NC complex. This is also within
the range of previously obtained full length affinity to ATP (160-230 µM) [6, 38]. The kon
and koff values can be seen in Table 3.2.
The net adenylation rate of the NC complex was estimated to be 500 s−1 , which is
about 105 times higher than the value we obtained for NFLuc alone (0.004 s−1 ). Previous
data suggests that full length luciferase would have a 100 times higher adenylation rate
than that in a full length mutant in which the C domain’s catalytic residues were selectively
mutated [6]. We believe that NFLuc alone has a much lower adenylation rate than that in
the mutant luciferase. The oxidation rate of the NC complex, 0.219 s−1 , is very close to
experimental values for full length luciferase (0.23 s−1 ) [6]. The oxidation rate of NFLuc
(4·10−7 s−1 ) is lower than the experimental values for a full length mutant in which the C
domain’s catalytic residues were selectively mutated (3.11 ·10−5 s−1 ) [6].
The frequency of dark reactions was previously predicted to increase from the 20%
of full length luciferase, and the curve fitting results suggest that both the NC complex
and NFLuc alone have a 29% dark reaction frequency [8]. The affinity of the intermediate
to the NC complex and NFLuc alone were both estimated to be 45 nM. This value is
much lower than previous experimental values for full length luciferase (4.7 µM) and a full
length mutant in which the C domain’s catalytic residues were selectively mutated (550 nM)
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(A)

(B)
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Figure 3.6: The mathematical model (red) reasonably matches data (black) at varying
concentrations of NFLuc-p53 and CFLuc-mdm2. (A) 50 nM of NFLuc-p53 and CFLucmdm2 each. (B) 150 nM of NFLuc-p53 and CFLuc-mdm2 each. (C) 450 nM of NFLuc-p53
and CFLuc-mdm2 each. Each simulation was separately optimized with respect to the
effects of the detection lens (photomultiplier tube). Data obtained from [28].
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Table 3.1: Comparison of Experimental and Estimated Values.
Parameter
LH2 Affinity
ATP Affinity
LH2 -AMP Affinity
L-oxy Affinity
L-AMP Affinity
Net Adenylation Rate
Oxidation Rate
Dark Reaction Frequency

Full length 
7.2-15 µM
160-230 µM
4.7 µM
500 nM
3.8 nM
100 §
0.23 s−1
0.2

NC complex
16 µM
160 µM
45 nM
70 nM
460 pM
500 s−1
0.219 s−1
0.29

NFLuc
27.5 µM
683 µM
45 nM
70 nM
23 pM
.004 s−1
4·10−7 s−1
0.29

NFLuc 
26-67 µM
560-6900 µM
550 nM
–
–
1§
3.11 ·10−5 s−1
> 0.2

: Values obtained from the literature [6, 38]. Values for luciferase without the catalytic residues

on the C domain are also reported here. : Estimated values obtained from the curve fit. § :
Values are relative to each other (e.g., a full length mutant in which the C domain’s catalytic
residues were selectively mutated has 100 times slower adenylation than the wild type.) [6].

[6]. However these experimental values suggest that the intermediate has higher affinity
to the mutant than to the wild type luciferase. Therefore our estimation, although quite
low, is tangentially supported by previous data. We believe that NFLuc, both alone and
in the NC complex, has a much higher affinity to the intermediate than the mutant luciferase.
The estimated values for the affinity of the inhibitors is also very low. The affinity
of L-amp to the NC complex and NFLuc alone is 460 pM, about 10 times higher than
the experimental value of 3.8 nM for full length luciferase [12, 25]. The affinity of L-oxy
to the NC complex and NFLuc alone is 70 nM, about 10 times higher than the previous
experimental value of 500 nM for full length luciferase [12, 25]. Since full length mutant
was observed to have 10 times lower affinity to the intermediate, it seems reasonable that
the mutant might also have 10 times lower affinity to the products as they are structurally
similar [6]. We therefore believe that NFLuc, both alone and in the NC complex, has much
lower affinity to the intermediate and the products than the full length mutant or wild type
luciferase.
3.1.4 The mathematical model reproduces the IC-50 curve of nutlin-3
The IC-50 can be defined as the point at which the observed binding of two proteins
is decreased by 50% by the ligand in question [91]. Ohmuro et al previously examined the
IC-50 of nutlin-3 using the in vitro FLCA [28]. Nutlin-3 inhibits the p53-mdm2 interaction
by binding to mdm2. The Ki of nutlin-3 was estimated using equation 3.2 [90]. The Ki is
an objective measurement of the affinity of a protein and its inhibitor [90]. The IC-50 and
the Ki are not perfectly correlated since the inhibitory ligand must compete with the target
protein’s other binding partner, among other factors [90]. A correction factor which takes
into account the strength of binding between the target protein and its binding partner and
the concentration of the proteins is therefore applied to the observed IC-50. Since the IC-50
is 350 +
25 nM with 100 nM of p53-NFLuc and mdm2-CFLuc, the calculated Ki is 216-250
−
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Table 3.2: Parameters Values from the Curve Fit
c1
c2
c3
c4
c5
c6
c7
c8
c9
c10
c11
c12
c13
c14
c15
c16
c17
c18
c19
c20
c21
c22
c23
c24
c25
c26
c27
c28

Kd,f Association of P53 and M DM2
9.2·106 M −1 s−1
Kd,r Dissociation of P53 and M DM2
2 s−1
kaf Association of LH2 to NC Complex
1.84·108 M −1 s−1
kar Dissociation of LH2 from NC Complex
3·103 s−1
klf Association of ATP to NC Complex
3·107 M −1 s−1
klr Dissociation of ATP from NC Complex
4.8·103 s−1
klf 2 Association of LH2 to NFLuc
1.84·108 M −1 s−1
klr2 Dissociation of LH2 from NFLuc
5.05·103 s−1
kaf 2 Association of ATP to NFLuc
3·107 M −1 s−1
kar2 Dissociation of ATP from NFLuc
2.05·104 s−1
kIf Adenylation rate, forward, NC complex
5.01·102 s−1
kIf Adenylation rate, reverse, NC complex
1.08·10−2 s−1
kif Adenylation rate, forward, NFLuc
5·10−2 s−1
kir Adenylation rate, reverse, NFLuc
1.1·10−2 s−1
kIf Association of Intermediate
7.77·107 M −1 s−1
kIf Dissociation of Intermediate
3.47 s−1
kcat Catalytic Rate NFLuc
4·10−7 s−1
kcat Catalytic Rate NC complex
2.191̇0−1 s−1
kif Association of Oxyluciferin to NC Complex
8.3·106 M −1 s−1
kir Dissociation of Oxyluciferin from NC Complex 6.13·10−1 s−1
kif 2 Association of L-AMP to NC Complex
5·107 M −1 s−1
kir2 Dissociation of L-AMP from NC Complex
2.3·10−5 s−1
Dark Reaction Frequency
2.871̇0−1
kif Association of Oxyluciferin to NFLuc
8.3·106 M −1 s−1
kir Dissociation of Oxyluciferin from NFLuc
6.13·10−1 s−1
kif 2 Association of L-AMP to NFLuc
5·107 M −1 s−1
kir2 Dissociation of L-AMP from NFLuc
2.3·10−5 s−1
Heat Degradation
1·10−3 s−1

Parameter values after optimization by curve fitting mathematical model to kinetic data.
Protein pair used in obtaining the experimental data for the curve fit was p53 and mdm2.
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Figure 3.7: Predicted nutlin-3 IC-50 curve (red) using in vitro FLCA agrees with the data
(black). Experimental RLU values from [28] at 0.2 s (black) compared with model predicted
RLU values (red) across a range of nutlin-3 concentrations, a specific binding inhibitor of
mdm2. The calculated IC-50 of the experimental data is 390 nM, while the simulation IC-50
is 440 nM.
nM [28]. The kon was estimated at 1 ·10−7 M −1 s−1 [29], and the initial guess for the Ki was
235 nM.
Ki =

IC50
[N F Luc]
+
Kd

1

(3.2)

The mathematical model was modified to reflect the three way interaction by the addition of ODEs describing the interaction of an inhibitor to a protein fused to CFLuc
(See appendix C) to ODE 2.1.3. The data used to calculate the IC-50 in the previously
published study were luminescence values (RLU) sampled at 0.2 s over a range of nutlin-3
concentrations. A total of 10 different concentrations of nutlin-3 were used, from 1 nM
to 16 µM [28]. The initial conditions of p53 and mdm2 were calculated to be incubated
to equilibrium prior to the addition of nutlin-3, as described in [28]. The model was then
used to simulate the IC-50 experiment, and equation 3.3 was used to calculate the IC-50
using the resulting data points [91]. The IC-50 value calculated by nonlinear regression
to this equation gave 390 nM for the experimental data and 440 nM for the model (Fig. 3.7).

Activity = max +
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(min − max)
(1 + ( [nutlin−3]
))
IC−50

(3.3)

Conclusion These results show that the model accurately represents the FLCA system.
The model is capable of matching NFLuc alone kinetics, experimental data over the long or
short term, several concentrations of NFLuc and CFLuc, and the nutlin-3 IC-50 curve. The
estimated values for the binding and catalysis rates are not unreasonable when compared
with values from the literature. We believe this demonstrates the model is representative of
the FLCA, and now we will use the model to analyze the FLCA data as being qualitative
or quantitative in nature.
3.2 Predictions of the mathematical model
3.2.1 The relationship between Kd and RLU is not intuitive
Although the observed luminescence (RLU) is correlated to the degree of interaction
between the protein pair of interest, it has been unknown how direct this correlation is. The
relationship between changes of the affinity of a protein pair and observed luminescence
was analyzed using the mathematical model.
The model suggests that the relationship between the Kd (the affinity of a protein pair)
and the RLU is exponentially rather than linearly correlated (Fig. 3.8). To obtain this data,
protein pair affinities were varied over 24 different values, from 2.5 nM to 3 µM. The kon
was held constant at a physiologically relevant 1 · 106 M −1 s−1 and the maximum RLU was
plotted [29]. This simulation demonstrates that the FLCA luminesence can be misleading
about the affinity of the protein pair. For example, when comparing the maximum RLU
at Kd 3 µM and .75 µM, the affinity increases 4 fold, but the RLU increases 6 fold (Fig.
3.8(B)). When comparing high affinities, for example 10 nM and 100 nM, the affinity increases 10 fold but the RLU increases 2 fold (Fig. 3.8(C)). This suggests that the FLCA
would be extremely misleading when considering protein pairs with very high affinity, but
more accurate for protein pairs with lower affinity.
Predicted effect of Kd on the kinetics of the FLCA The model predicts that the
peak RLU duering the FLCA assay decreases with the affinity of the protein pair fused
to NFLuc and CFLuc (Fig. 3.9). To simulate this relationship, protein pair affinities were
varied over 24 different values, from 2.5 nM to 3 µM. The kon was held constant at a
physiologically relevant 1 · 106 M −1 s−1 and the kinetics were plotted for 100 s [29]. As the
Kd decreases, the kinetics shift from having a sharp peak RLU and consequent decay, to
being nearly flat.
It is not unreasonable to look for a luminesence signal that is above background to
identify the presence of a protein-protein interaction when using the FLCA. For protein
pairs above 1 µM, the peak RLU is predicted to be very flat and low in magnitude, such
that it may appear to be a non-interacting pair (Fig. 3.9(A)).
In Fig. 3.9(A), the concentration of NFLuc and CFLuc were held constant at 50 nM
each. This is significantly below the Kd of the very low affinity protein pairs which might
appear to be non-interacting (i.e. 1 µM and above). To observe the effect of a more appropriate concentration for this affinity range, the concentration was raised to 1 µM in Fig.
3.9(B). This improved peak definition in the lower Kd range, but did not completely solve
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(B)
(B)
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Figure 3.8: Directly comparing RLU obtained by the FLCA with different protein pairs
may cause misunderstandings about their affinities. (A) The model predicts an exponential
relationship between changes of Kd and maximum RLU. (B) For protein pairs that have
low Kd (i.e., Kd varied between 2.5-100 nM), comparing RLU underestimates changes of
the affinity. An RLU twice as high correlates with Kd s 10 times as high. (C) For protein
pairs that have high Kd (i.e., Kd is between 0.5-3 µM), the changes in RLU are somewhat
closer to changes in Kd . An RLU twice as high correlates with a Kd 1.5 times higher.
the issue. When the concentration of NFLuc and CFLuc is increased in this manner, the
peak RLU for higher affinity protein pairs begins to cluster more tightly. For such assay
conditions, directly comparing protein pairs of different affinities must be qualitative.
These findings raise a question of the validity of the previous interpretation of the FLCA
conducted in the past. Some previous papers claim that the RLU and the Kd are linear
[41, 51]. Even when we assume that in vitro and in vivo reaction conditions are identical, the
RLU detected underestimates the Kd of a protein pair. It is conceivable that experimental
errors occur more often in vivo than in vitro. It is also conceivable that reaction conditions
in vitro and in vivo are largely different [68]. Therefore, we suggest that the FLCA data
published in the past were qualitative assays if the RLU of a protein pair was directly
compared to another protein pair.
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(A)

(B)

Figure 3.9: Model predicts that peak definition decreases as Kd increases. The model was
solved for 24 Kd s which were from 2.5 nM to 3 µM and the kinetics were plotted over 100 s.
Each subsequent Kd is plotted in a different color. (A) The model suggests that as the Kd
decreases, the peak definition is slowly lost, to the point of appearing flat and steady. For
high Kd s, such as 1 to 3 µM, the luminesence may be confused with the background. (B)
Increasing the concentration of enzyme from 50 nM to 1 µM causes more defined peaks in
low Kd pairs, but less difference between peaks.
3.2.2 Suggested in vitro experimental design for quantitative FLCA
The model created in this study can aid in the design of an in vitro experiment to
obtain the Kd for a protein pair of interest. We suggest to obtain a satruation binding curve
using increasing titrations of CFLuc. This will enable the identification of the 50% binding
point, or the Kd , using nonlinear curve fitting to the data set using equation 3.4 [29]. The
feasibility of this in vitro is demonstrated by the IC-50 curve results, as this is another type
of saturation curve.
We suggest titrating a protein fused to CFLuc over a large series of concentrations while
using a constant, minimal concentration of a protein fused to NFLuc [29]. The lower the concentration of NFLuc, the less CFLuc is needed to fully saturate NFLuc. The concentrations
of LH2 and ATP should be kept at a constant, saturating level during the experiment. Then
the maximum RLU observed during the assay for each different concentration of CFLuc
added should be collected. To ensure that NFLuc is completely bound, we suggest that
the same maximum RLU should be obtained with two separate concentrations of CFLuc.
A loss in accuracy is to be expected if 0% and 100% bound NFLuc are not measured [29, 90].
The Kd can be then calculated by nonlinear regression to a quadratic formula which
expresses the relationship between binding and Kd (Eqn. 3.4) [29]. The simulation results
are shown in Fig. 3.10. For this simulation, the Kd of the protein pair was set to 100 nM and
the kon was set at 1·106 M −1 s−1 [29]. The concentration of NFLuc was set to 1 nM, and 20
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Figure 3.10: The Kd can be obtained by the FLCA in vitro by nonlinear regression (blue)
to the saturation curve formed by peak RLU values (red). By titrating CFLuc from 1·10−3
nM to 1·103 µM while NFLuc is held at 1 nM, the predefined Kd (shown here, 100 nM) can
be reasonably re-obtained at 83 nM. To properly estimate Kd , the same maximum RLU
must be obtained multiple times, to establish that NFLuc cannot be bound to any more
CFLuc. For a Kd of 100 nM, approximately 100µM is required to accomplish this. After
finding the point at which 100% NFLuc is bound to CFLuc, the maximum RLU points are
normalized to one. The Kd is calculated using the maximum RLU and linear regression to
a quadratic formula described previously [29] to find the concentration of CFLuc required
to reach 50% saturation.
different concentrations of a protein fused to CFLuc was varied from 100 pM to 1·106 nM.
100 pM was used to establish near 0% binding. The maximum RLU was calculated, and
linear regression was performed to a quadratic formula describing the relationship between
% bound N and Kd (equation 3.4) [29]. Nonlinear regression to this equation provided an
estimated Kd of 83 nM. The predicted kinetics of this experiment are shown in Fig. 3.11.

Bound N =

[N ] + [C] + Kd − ([N ] + [C] + Kd2 − 4 · [N ] · [C]0.5 )
2 · [N ]

(3.4)

The model suggests that a pitfall of this experiment is requirement of high concentrations
of CFLuc to complete the titration curve. A complete titration curve requires both values
corresponding to 0% and 100% activity [29]. For instance, if one only titrates CFLuc up to 1
µM, 100 times less than the simulated maximum of 100 µM, the estimated Kd obtained via
nonlinear regression is 65 nM. If one titrates CFLuc up to 10 µM however, 10 times less than
the simulated maximum of 100 µM. the estimated Kd is 81 nM, a small reduction in accuracy.
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3.2.3 Conclusion
In this study, we found that the cause of the change in luminescence kinetics between full
length and split firefly luciferase is due primarily to decreases in the adenylation and oxidation rates, in addition to the transient nature of the interaction between NFLuc and CFLuc.
Branchini et al first demonstrated the effect of the removal of the C terminal domain’s
catalytic residues by measuring the luminescence production in a recombinant protein [6].
The mathematical model and parameter estimation results agree with previously obtained
binding and catalytic values. The model also demonstrates that these kinetic effects cause
the relationship between luminescence and the affinity of the protein pair fused to NFLuc
and CFLuc to be exponential rather than linear. The model explains that although it is
possible to obtain qualitative information of the protein-protein interaction (whether or not
the proteins interact) by comparing two sets of FLCA data, the non intuitive relationship
between RLU and Kd of a protein pair prevents such comparisons from being quantitative.
The simulations demonstrates that the FLCA can be used to obtain quantitative information about the protein pair of interest if a large range of titration experiments are conducted
to obtain a saturation curve.
Although the FLCA is a convenient and cost-effective assay to analyze protein-protein
interactions both in vitro and in vivo, utilizing the FLCA as a quantitative assay remains
a challenge. One of the most challenging aspects is to understand how the ”active site” of
firefly luciferase is reconstituted when the proteins fused to NFLuc and CFLuc interact. It
is known that when NFLuc and CFLuc are fused to different locations of a protein pair
(.i.e., amino- or carboxyl- terminal end of proteins of interest), the RLU observed in the
FLCA assay varies greatly [28]. This shows that the geometry of NFLuc and CFLuc in
the interacting protein complex can largely influence how the active site is reconstituted.
This phenomenon particularly demonstrates how directly comparing RLU between protein
pairs must be considered qualitative. Although the geometry of the interacting protein
complex will vary depending on the proteins of interest and the recombinant areas, it seems
reasonable that the geometry of NFLuc and CFLuc in the interacting protein complex
would not change significantly based on different environmental conditions (such as pH, the
presence of small compounds, etc). Accordingly, one may assume that the FLCA can be used
to compare the quantitatively obtained Kd s directly, regardless of different environmental
conditions. However the I model created in this thesis explains that obtaining the Kd of a protein pair requires a saturation curve, regardless of the environmental or geometric conditions.
FLCA is thought to be most useful in vivo [68]. However, because expressing large
concentrations of proteins in vivo is not always feasible, the quantitative FLCA (i.e., determining Kd of a protein pair) may not be feasible for in vivo with the current experimental
design. The identification of kon and koff in vitro afford another challenge. Identification of
the kon would be relatively simple, using the same method as described for the measurement of the Kd . Measuring the koff must require further experimental design, however, as it
requires the addition of competing proteins during the kinetic reaction. Since luciferase is
inhibited by its products, such an experiment would require either math modeling to aid
in data interpretation, or the use of a different system that does not experience product
inhibition. The future goal of this project is to analyze the suitability of the quantitative
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Figure 3.11: Predicted kinetics upon the titration of CFLuc to a constant level of NFLuc.
CFLuc was titrated with 20 different concentrations, varying from 100 pM to 1·106 nM.
The model shows that as the concentration of CFLuc increases, the peak will become more
and more defined, until it reaches some maximum. Each subsequent simulation is plotted
in a different color. 100 pM of CFLuc lies on the x-axis and 75·105 and 1·106 nM overlap
to form the highest peak.
FLCA for the measurement of the koff , as well as the suitability of the quantitative FLCA
for in vivo applications.
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Chapter 4
Materials and Methods
4.1 Materials and Methods
4.1.1 Experimental
Measurement of the kinetics of full length firefly luciferase Full length firefly
luciferase data was collected under similar conditions as in [28]. Briefly, ATP and LH2 were
purchased from Thermo Scientific (Rockford, IL). MOPS was from Acros Organics (Thermo
Fisher Scientific, Geel, Belgium). Firefly luciferase was purchased from Promega (Wisconsin,
USA). Luciferase enzyme was suspended in 100 mM MOPS, 19 mM MgSO4 , pH 7.3. 1 µL
of the enzyme solution and 50 µL of a 2x ATP solution (40 mM ATP in 100 mM MOPS, 10
mM MgSO4 , pH 7.3) was dispensed to a well in a white 96-well plate (Corning-Costar, NY,
USA). The luminescence was measured immediately after injection of a 2x LH2 solution
(150 µM LH2 , 100 mM MOPS, 10 mM MgSO4 , pH 7.3) with periodical integration for 0.2
s for 120 s using Synergy 2 luminometer (Biotek, Vermont, USA).
4.1.2 Calculations
Calculation of the degradation of split firefly luciferase. Degradation analysis due
to heat inactivation was performed previously [28]. The maximum RLU for each incubation time was digitized using PlotDigitizer and normalized [16]. The degradation rate was
calculated by curve fitting an equation describing exponential degradation 3.1. The curve
fit was accomplished using Matlab’s nlinfit function for nonlinear equations [26].
Estimation of parameters Initial estimates for parameters were taken from the literature (Table 1.1). Initial estimates for all kon rates were held between the physiologically
relevant range of 105 − 108 M −1 [29]. Parameters unavailable from the literature were estimated by curve fitting the model to previous data. The parameters we needed to estimate
were the adenylation rates, and the dark reaction frequency. Previous data suggests relative
adenylation rates [6], but no forward or reverse rate estimates were available. Measuring
the adenylation rate directly is a technical challenge as its product is pyrophosphate and
enzyme bound to the intermediate [6]. Previous mutagenesis data suggested an increase in
dark reaction frequency but the exact value is unknown [25, 6].
To estimate these values, NFLuc only data was digitized from previously published data
using PlotDigitizer [3, 16]. The mathematical model (ODE 2.1.3) was modified to remove all
references to CFLuc and the NC complex prior to curve fitting (ODE 4.1.2). Curve fitting
to the luminescence kinetics obtained when LH2 and ATP were added provided estimates
for the adenylation rates and dark reaction frequency. The curve fit to the luminescence
kinetics obtained with the addition of LH2 -AMP alone provided improved estimates for the
oxidation rate and intermediate affinity.
Functions utilized by the model The ODE was solved with MatLab’s ode23s for stiff
systems [26]. Our ODEs were determined stiff by the relative computation time to solve
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the ODEs. ode45 took several minuts, while ode23s took only 1.4 seconds to solve the
entire system of ODEs. ode23s solves the differential equations over a defined timespan
with defined timesteps. Our timespan and timesteps was defined by the data set. A vector
of initial conditions is supplied to provide starting values for the calculations.
The curve fitting was done using MatLab’s lsqcurvefit function. lsqcurvefit optimizes an
input vector of parameters by calculating the squared difference between the model output
and the data. It then changes the values of parameters by small increments until improvement is made upon this squared difference. The parameters are kept within user-defined
numeric boundaries, supplied to the lsqcurvefit function in the form of vectors.
The calculation of IC-50 and Kd values were accomplished using nlinfit in Matlab [26].
For the specified nonlinear function, nlinfit calculates best-ft values for variables contained
within the function. nlinfit uses an iterative reweighted least squares algorithm to optimize
the values given vectors containing the observed data values and the input values (such
as time). The weights given to a parameter within the function are recalculated with each
successive iteration.
Calculation of initial conditions The model calculates the initial concentrations of
non-interacting and interacting protein pair prior to running a simulation. This is calculated using the kon and kof f for the protein pair, the initial concentration of the proteins,
the degradation rate of split firefly luciferase, and the incubation time with the system
of equations shown in Appendix C (ODE C1). The kon and kof f of the protein pair was
obtained from a previous paper [31]. The initial concentration of the proteins was determined experimentally. The incubation time was approximated at 1 s due to delays of the
substrate injection by the machine if no incubation time was defined by the experimenters.
The degradation rate was calculated by curve fitting to previously obtained data [28]. FLCA
proteins were incubated at 37  for 0 to 60 minutes and the resulting activity monitored.
The maximum RLU was obtained from this data using PlotDigitizer. The maximum RLU
at 0 minutes incubation was assumed to represent 100% activity.
Curve fit After obtaining parameter estimates for NFLuc alone, estimates for NC complex binding and catalysis rates were taken from the literature. The system of ODE was
curve fit using lsqcurvefit to data obtained by our collaborators in this project. The effect
of the light sensor (photomultiplier tube) was negated by normalizing data and model simulations. In most cases the peak will be the maximum RLU of a data set. However, in the
long term data set, a few outliers can be observed which causes normalization to be non
ideal. For this data set, therefore, the magnification effect of the photomultiplier tube was
optimized as well. After obtaining the parameters, the model was compared to previously
published p53-mdm2 data under various concentrations [28]. To eliminate variations due
to the photomultiplier tube, the data and model output were normalized.
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ODE 4.1.2
Stripped-down ODEs describing the binding and catalysis interactions of NFLuc only
dx1
= −c9 · x1 · x6 + c10 · x16 − c7 · x1 · x3 + c8 · x15 − c24 · x1 · x14 + c25 · x19
dt
− c26 · x1 · x12 + c27 · x20 − c15 · x1 · x9 + c16 · x18
dx3
= −c7 · x1 · x3 + c8 · x15 − c7 · x16 · x3 + c8 · x17
dt
dx6
= −c9 · x1 · x6 + c10 · x16 − c9 · x15 · x6 + c10 · x17
dt
dx9
= −c15 · x2 · x9 + c16 · x8 − c15 · x1 · x9 + c16 · x18
dt
dx12
= −c21 · x2 · x12 + c22 · x11 − c26 · x1 · x12 + c27 · x20
dt
dx13
= −x13 + c17 · x18 · (1 − c23 ) · c19
dt
dx14
= −c24 · x1 · x14 + c25 · x19
dt
dx15
= c7 · x1 · x3 − c8 · x15 − c9 · x15 · x6 + c10 · x17
dt
dx16
= c9 · x1 · x6 − c10 · x16 − c7 · x16 · x3 + c8 · x17
dt
dx17
= −c13 · x17 + c14 · x18 + c9 · x15 · x6 − c10 · x17 + c7 · x16 · x3 − c8 · x17
dt
dx18
= c13 · x17 − c14 · x18 − c17 · x18 + c15 · x1 · x9 − c16 · x18
dt
dx19
= c17 · (1 − c23 ) · x18 + c24 · x1 · x14 − c25 · x19
dt
dx20
= c17 · c23 · x18 + c26 · x1 · x12 − c27 · x20
dt
Simulation of inhibition To simulate the inhibition of p53 and mdm2 by nutlin-3, as
performed in [28], the model (ODE 2.1.3) was modified to reflect a three-way molecular
interaction (ODE C2, appendix C). The initial concentrations were calculated prior to the
simulation as the previous paper described an incubation step [28]. The initial conditions for
this three-way interaction were calculated using ODE C3 (See appendix C). The experiment
used 100 nM of NFLuc and CFLuc with concentrations of nutlin-3 varying from 1 nM to
16 µM. The experimental values were taken at 0.2 s. To calculate the IC-50, the RLU at
0.2 s were plotted and the IC-50 values were calculated. These points were fit using nonlinear regression to equation 3.3. Nonlinear regression and plotting was accomplished using a
modified form of the independently designed DoseResponse package for Matlab [40]. The default equation for the DoseResponse package was changed to reflect the goals of the curve fit.
Relationship of RLU to Kd To examine the relationship between the maximum RLU
and the Kd of the attached protein pair, a range of 24 Kd s were used, with the value varied
from 2.5 nM to 3 µM. The kon was held constant at 1·107 M −1 s−1 [29]. Initial concentra33

tions of p53 and mdm2 fusing to NFLuc and CFLuc, respectively, were 50 nM each. The
maximum RLUs were compared.
Prediction of Kd To determine the ability of the FLCA to detect the Kd of the attached
protein pair, the concentration of CFLuc was varied from 1 · 10−3 nM to 1 · 106 nM while the
concentration of NFLuc was held constant at 1 nM. This range was determined by ensuring
the maximum RLU could not be increased by increasing the protein fused to CFLuc. This
was determined by obtaining the maximum RLU multiple times. The maximum RLU of
each CFLuc concentration was plotted, and the highest RLU was considered 100% bound
NFLuc. These points were fit using nonlinear regression to equation 3.4 [29].
To determine Kd , the equation was solved using nonlinear regression for the concentration of the protein fused to CFLuc corresponding to 50% bound NFLuc. Nonlinear
regression was accomplished using Matlab’s nlinfit function. The resulting estimated Kd
was compared to the Kd defined for the interaction between the simulated protein pair fused
to the NFLuc and CFLuc, respectively.
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Appendix A
Matlab Code
1
2
3
4
5
6

function main
%%%%%%%%%%%%%%%%%
%%NC parameters
%luciferin
c3=184;
c4=2.999999605697860e+03;

7
8
9
10

%ATP
c5=30;
c6=4.799990417951311e+03;

11
12
13
14

%adenylation rate
c11=5.005032362403402e+02;
c12=1.075165513854852e-02;

15
16
17

%kcat
c18=2.186046521866479e-01;

18
19
20
21

%L-oxy
c19=8.296207031450622e+00;
c20=6.132100294976869e-01;

22
23
24
25
26
27
28
29
30

%L-AMP
c21=5.000500240288718e+01;
c22=2.276804780286590e-05;
%%%%%%%%%%%%%%%%%
%%N domain parameters
%luciferin
c7=1.840621857623435e+02;
c8=5.049917207781118e+03;

31
32
33
34

%ATP
c9=2.994060619739656e+01;
c10=2.049501880555152e+04;

35
36
37
38

%adenylation rate
c13=5.496651143939792e-02;
c14=1.100207814311677e-02;

39
40
41

%kcat
c17=3.993565543918900e-07;

42
43
44
45

%L-oxy N
c24=8.296207031450622e+00;
c25=6.132100294976869e-01;

46
47

%L-AMP N

43

48
49
50
51
52
53
54
55

c26=5.000500240288718e+01;
c27=2.276804780286590e-05;
%%%%%%%%%%%%%%%%%
%%shared parameters
%p53-mdm2
c2=2;
c1=9.2;
kd=.212;

56
57
58

%dark reactions
c23=2.870910570336138e-01;

59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84

%intermediate
c15=7.771865248970217e+01;
c16=3.471656490390523e+00;
%%%%%%%%%%%%%%%%%
%degradation during incubation
%c28=.00136;%37 deg heat
c28=0;%no heat
%%%%%%%%%%%%%%%%%
%determine initial concentration
ini n=.05;
%ini n=.15;
%ini n=.45;
ini c=ini n;
%incub time=1;
incub time=120;
Q=[ini n;kd;c2;c28;incub time;ini c;];
[nconc]=plot KDp(Q);
initN=nconc(1);
initC=nconc(3);
initNC=nconc(2);
%%%%%%%%%%%%%%%%%
%%DATA
%%%%long term
ydata = xlsread('50nm split.xlsx','B2:B1202');
tdata = xlsread('50nm split.xlsx','A2:A1202');

85
86
87
88
89
90
91
92
93
94
95
96
97

98
99
100

%%%short term
%tdata=xlsread('50nm 4s.xlsx','A4:A43');
%ydata=xlsread('50nm 4s.xlsx','B4:B43');
%ydata = xlsread('150nm 4s.xlsx','B4:B43');
%ydata = xlsread('450nm 4s.xlsx','B4:B43');
%%%%%%%%%%%%%%%%%
%solve ODEs
options = odeset('RelTol',1e-6);%,'MaxOrder','1','BDF','on');
Xo=[initN;initNC;75;0;0;10000;0;0;0;0;0;0;0;0;0;0;0;0;0;0;initC;];
%Xo=[0;ini n;75;0;0;10000;0;0;0;0;0;0;0;0;0;0;0;0;0;0;0;];
tspan=tdata;
[t,X]=ode23s(@p53ode,tspan,Xo,options,c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c11,...
c12,c13,c14,c15,c16,c17,c18,c19,c20,c21,c22,c23,c24,c25,c26,c27);
%%%%%%%%%%%%%%%%%
%plot
%% normalize data
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%ynorm=ydata./max(ydata);
%simnorm=X(:,13)./max(X(:,13));
%plot(tdata,ynorm,'ok',t,simnorm,'r','LineWidth',2);
%% use gain
%ygain=3.041357255478377e+06.*X(:,13); %50 nM long term
%ygain=5.3513e+06.*X(:,13); %50 nM short term
%ygain=6.7415e+06.*X(:,13); %150 nM
%ygain=6.5734e+06.*X(:,13); %450 nM
%plot(tdata,ydata,'ok','LineWidth',2);
%hold on
%plot(t,ygain,'r','LineWidth',2);
%% plot options
set(gca,'FontSize',12,'FontName','Arial');
xlabel('Time (s)');ylabel('RLU');
%% plot individual portions of ODE
%subplot(4,3,1);plot(t,X(:,4),'m','LineWidth',2);title('nca'); subplot...
(4,3,2);plot(t,X(:,5),'m','LineWidth',2);title('cnl');
%subplot(4,3,3);plot(t,X(:,7),'m','LineWidth',2);title('ncla'); subplot...
(4,3,4);plot(t,X(:,8),'m','LineWidth',2);title('ncLA');
%subplot(4,3,5);plot(t,X(:,17),'m','LineWidth',2);title('nla'); subplot...
(4,3,6);plot(t,X(:,18),'m','LineWidth',2);title('nLA');
%subplot(4,3,7);plot(t,X(:,5),'m','LineWidth',2);title('cna'); subplot...
(4,3,8);plot(t,X(:,5),'m','LineWidth',2);title('CNl');
%subplot(4,3,9);plot(t,X(:,10),'m','LineWidth',2);title('Noxy'); subplot...
(4,3,10);plot(t,X(:,14),'m','LineWidth',2);title('oxy');
%subplot(4,3,11); plot(t,X(:,13),'m','LineWidth',2);title('light');%...
subplot(4,3,12); plot(tdata,ydata);
return
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%function to solve initial conditions
function init=plot KDp(Q)
options = odeset('RelTol',1e-6);
initN=Q(1);initC=Q(6);initNC=0;
kd=Q(2);cr=Q(3);cf=cr/kd;deg=Q(4);
Xo=[initN;initC;initNC;];
if Q(5) == 0 %no incubation
init=[Q(1);Q(6);0;]; %return provided initial conditions
return
end
tend=Q(5);
tspan=0:tend;
[t,X]=ode15s(@odeKD,tspan,Xo,options,cf,cr,deg);
%% plot initial conditions
%plot(t,X(:,1),t,X(:,3),'Linewidth',2);
%set(gca,'FontSize',12,'FontName','Arial');
%legend('[N]','[NC]');xlabel('Time (s)');ylabel('Concentration (uM)');
A=X(tend,1);
B=X(tend,3);
C=X(tend,2);
init=[A;B;C;];
return
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%ODE for initial conditions
function[dx dt]=odeKD(t,x,cf,cr,deg)
dx dt(1)=-cf.*x(1).*x(2)+cr.*x(3)-deg.*x(1);
dx dt(2)=-cf.*x(1).*x(2)+cr.*x(3)-deg.*x(2);

45

149
150
151
152
153

154
155

156

157

158

159

160

161

162

163
164

165

166
167
168
169

170

171

172

173

174

175

176
177

dx dt(3)=cf.*x(1).*x(2)-cr.*x(3)-deg.*x(3);
dx dt=dx dt';
return
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
function[dx dt]=p53ode(t,x,c1,c2,c3,c4,c5,c6,c7,c8,c9,c10,c11,c12,c13,c14,...
c15,c16,c17,c18,c19,c20,c21,c22,c23,c24,c25,c26,c27)
%ODE
dx dt(1)=-c1.*x(1).*x(21)+c2.*x(2)-c9.*x(1).*x(6)+c10.*x(16)-c7.*x(1).*x...
(3)+c8.*x(15)-c24.*x(1).*x(14)+c25.*x(19)-c26.*x(1).*x(12)+c27.*x(20)-...
c15.*x(1).*x(9)+c16.*x(18);
dx dt(2)=c1.*x(1).*x(21)-c2.*x(2)-c3.*x(2).*x(3)+c4.*x(4)-c5.*x(2).*x(6)+...
c6.*x(5)-c21.*x(2).*x(12)+c22.*x(11)-c19.*x(2).*x(14)+c20.*x(10)-c15.*...
x(2).*x(9)+c16.*x(8);
dx dt(3)=-c3.*x(2).*x(3)+c4.*x(4)-c3.*x(5).*x(3)+c4.*x(7)-c7.*x(1).*x(3)+...
c8.*x(15)-c7.*x(16).*x(3)+c8.*x(17);
dx dt(4)=c3.*x(2).*x(3)-c4.*x(4)-c5.*x(4).*x(6)+c6.*x(7)+c1.*x(15).*x(21)-...
c2.*x(4);
dx dt(5)=-c3.*x(5).*x(3)+c4.*x(7)+c5.*x(2).*x(6)-c6.*x(5)+c1.*x(16).*x(21)...
-c2.*x(5);
dx dt(6)=-c5.*x(2).*x(6)+c6.*x(5)-c5.*x(4).*x(6)+c6.*x(7)-c9.*x(1).*x(6)+...
c10.*x(16)-c9.*x(15).*x(6)+c10.*x(17);
dx dt(7)=c3.*x(5).*x(3)-c4.*x(7)+c5.*x(4).*x(6)-c6.*x(7)+c1.*x(17).*x(21)-...
c2.*x(7)-c11.*x(7)+c12.*x(8);
dx dt(8)=c11.*x(7)-c12.*x(8)+c1.*x(18).*x(21)-c2.*x(8)-c18.*x(8)+c15.*x(2)...
.*x(9)-c16.*x(8);
dx dt(9)=-c15.*x(2).*x(9)+c16.*x(8)-c15.*x(1).*x(9)+c16.*x(18);
dx dt(10)=c18.*x(8).*(1-c23)+c1.*x(19).*x(21)-c2.*x(10)+c19.*x(2).*x(14)-...
c20.*x(10);
dx dt(11)=c18.*c23.*x(8)+c1.*x(20).*x(21)-c2.*x(11)+c21.*x(2).*x(12)-c22.*...
x(11);
dx dt(12)=-c21.*x(2).*x(12)+c22.*x(11)-c26.*x(1).*x(12)+c27.*x(20);
dx dt(13)=c18.*x(8).*(1-c23)-x(13)+c17.*x(18).*(1-c23);
dx dt(14)=-c19.*x(2).*x(14)+c20.*x(10)-c24.*x(1).*x(14)+c25.*x(19);
dx dt(15)=c7.*x(1).*x(3)-c8.*x(15)-c9.*x(15).*x(6)+c10.*x(17)-c1.*x(15).*x...
(21)+c2.*x(4);
dx dt(16)=c9.*x(1).*x(6)-c10.*x(16)-c7.*x(16).*x(3)+c8.*x(17)-c1.*x(16).*x...
(21)+c2.*x(5);
dx dt(17)=-c13.*x(17)+c14.*x(18)+c9.*x(15).*x(6)-c10.*x(17)+c7.*x(16).*x...
(3)-c8.*x(17)-c1.*x(17).*x(21)+c2.*x(7);
dx dt(18)=c13.*x(17)-c14.*x(18)-c1.*x(18).*x(21)+c2.*x(8)-c17.*x(18)+c15.*...
x(1).*x(9)-c16.*x(18);
dx dt(19)=c17.*(1-c23).*x(18)-c1.*x(19).*x(21)+c2.*x(10)+c24.*x(1).*x(14)-...
c25.*x(19);
dx dt(20)=c17.*c23.*x(18)-c1.*x(20).*x(21)+c2.*x(11)+c26.*x(1).*x(12)-c27....
*x(20);
dx dt(21)=-c1.*x(21).*x(1)-c1.*x(21).*x(15)-c1.*x(21).*x(16)-c1.*x(21).*x...
(17)-c1.*x(21).*x(20)-c1.*x(21).*x(19)+c2.*x(2)+c2.*x(4)+c2.*x(5)+c2.*...
x(11)+c2.*x(10)+c2.*x(7)-c1.*x(21).*x(18)+c2.*x(8);
dx dt=dx dt';
return
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Appendix B
Full Length Simulation
Fit to full length data Using the model, we can approximate the full length kinetics
(Fig. B). Either because of the kinetics, or because of machine error, the data started out
at the peak. To approximate this using the model, the affinity between the proteins fused
to NFLuc and CFLuc was set to 0. The parameters were then altered to find the earliest
peak, which occurred between 2-3 s. The model was simulated from 3 s onward, cutting
off the peak. This simulation predicts that, relative to the NC complex, full length firefly
luciferase has a higher affinity to L-oxy but a lower affinity to L-AMP, less dark reactions,
and a moderately higher oxidation rate (Table B). Interestingly, improvements made in
neither the adenylation rate nor the substrate affinity seems to affect the kinetics.

Figure B.1: Simulation of full length firefly luciferase kinetics using the FLCA model. By
altering some of the parameters, the FLCA model can look like full length data.

Table B.1: Parameter Comparison
Parameter
NC complex
Oxidation rate 0.22 s−1
L-oxy affinity
70 nM
L-AMP affinity 460 pM
Dark reactions 0.2

Full simulation Full length (from [6])
0.3 s−1
0.167 s−1
6 nM
500 nM
5.2 nM
3.8 nM
0.29
0.2
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Appendix C
Additional ODEs
ODE C1.
System of ODEs describing the interaction and degradation of two proteins.
dx1
= −c1 · x1 · x2 + c2 · x3 − c3 · x1
dt
dx2
= −c1 · x1 · x2 + c2 · x3 − c3 · x2
dt
dx3
= c1 · x 1 · x 2 − c2 · x 3 − c3 · x 3
dt

Key to ODE C1
c1
c2
c3
x1
x2
x3

kon
koff
degradation
NFLuc
CFLuc
NC complex

ODE C2
Equations describing the binding of an inhibitor to a protein bound to CFLuc.
dx21
= ... − c25 · x21 · x22 + c26 · x23
dt
dx22
= −c25 · x21 · x22 + c26 · x23
dt
dx23
= c25 · x21 · x22 − c26 · x23
dt
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Key to ODE C2
c25
c26
x21
x22
x23

Ki forward
Ki reverse
CFLuc
Free inhibitor
CFLuc-Inhibitor complex

ODE C3.
Equations describing the interaction between two proteins and one inhibitor.
dx1
= −c1 · x1 · x2 + c2 · x3
dt
dx2
= −c1 · x1 · x2 + c2 · x3 − c3 · x4 · x2 + c4 · x5
dt
dx3
= c1 · x 1 · x 2 − c2 · x 3
dt
dx4
= −c3 · x4 · x2 + c4 · x5
dt
dx5
= c3 · x 4 · x 2 − c4 · x 5
dt

Key to ODE C3
c1
c2
c3
c4
x1
x2
x3
x4
x5

kon
koff
Ki forward
Ki reverse
NFLuc
CFLuc
NC complex
Free inhibitor
CFLuc-inhibitor complex
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Appendix D
Material and Methods for the FLCA
Measurement of the kinetics of in vitro FLCA Kinetic data of luminescence production in FLCA was obtained by our collaborators under the same conditions as previously
published in [28]. Briefly, purified recombinant protein of p53 and mdm2 fused to NFLuc
and CFLuc (50 nM) were suspended in a 2x enzyme solution containing 100 mM MOPS,
10 mM MgSO4 , pH 7.3. The mixture (50 µl) was dispensed to a well in a white 96-well
plate (Corning-Costar, NY, USA) after incubation at 37◦ C for 120 s. The light intensity
was measured immediately after injection of 50 µl 2x substrate solution (40 mM ATP and
150 µM LH2 in 100 mM MOPS, 10 mM MgSO4 , pH 7.3) with a periodical integration for
0.1 s using Phelios AB-2350 luminometer (ATTO, Tokyo, Japan).
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